We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Image: The model combines digitized tumor histopathology, clinical variables, and a 42-gene molecular panel using AI to generate a unified recurrence risk prediction (Image Credit: Shutterstock)

Multimodal AI Improves Breast Cancer Recurrence Risk Prediction Beyond Standard Genomic Testing

A new multimodal AI test improves early and late distant recurrence prediction in HR+/HER2- breast cancer. More...
21 Sep 2026
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

A new multiomic blood test uses 5hmC, genomic, and glycan signals to noninvasively monitor therapy and subtype pancreatic cancer. More...
21 Sep 2026
Image Credit: Shutterstock

Rare Genetic Variant Linked to Dramatically Higher Lung Cancer Risk

New data link rare inherited EGFR variant to 25-fold higher lung cancer risk, informing genetic screening. More...
21 Sep 2026
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Mayo Clinic and Thermo Fisher Scientific aim to help researchers better understand early biological changes that precede diagnosis. More...
21 Sep 2026
Image

Sputum-Based Lung Cancer Test Technology Granted Hong Kong Patent

CyPath Lung by bioAffinity Technologies is a noninvasive test designed to improve early lung cancer detection in high-risk patients. More...
21 Sep 2026
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

New data show CGM metrics flag higher hypertension and cholesterol risk in adults without diabetes. More...
18 Sep 2026
Image Credit: Shutterstock

Multimodal AI Improves Treatment Response Prediction in Lung Cancer

An AI approach integrates multimodal routine data to predict NSCLC immunotherapy response and survival. More...
18 Sep 2026
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gastrointestinal Panel
Xpert® GI Panel
Automatic CLIA Analyzer
Shine i6000